200 related articles for article (PubMed ID: 29074425)
41. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
42. IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation.
Liu CC; Lin JH; Hsu TW; Su K; Li AF; Hsu HS; Hung SC
Int J Cancer; 2015 Feb; 136(3):547-59. PubMed ID: 24947242
[TBL] [Abstract][Full Text] [Related]
43. Chimeric antibody targeting SRPK-1 in the treatment of non-small cell lung cancer by inhibiting growth, migration and invasion.
Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q
Mol Med Rep; 2017 Aug; 16(2):2121-2127. PubMed ID: 28656224
[TBL] [Abstract][Full Text] [Related]
44. Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Phan AN; Hua TN; Kim MK; Vo VT; Choi JW; Kim HW; Rho JK; Kim KW; Jeong Y
Oncotarget; 2016 Aug; 7(34):54702-54713. PubMed ID: 27419630
[TBL] [Abstract][Full Text] [Related]
45. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
46. HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway.
Pan J; Qin Y; Zhang M
Biomed Pharmacother; 2016 Feb; 77():176-81. PubMed ID: 26796282
[TBL] [Abstract][Full Text] [Related]
47. Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer.
Teng MR; Huang JA; Zhu ZT; Li H; Shen JF; Chen Q
Pathol Res Pract; 2019 Jun; 215(6):152417. PubMed ID: 31043353
[TBL] [Abstract][Full Text] [Related]
48. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
[TBL] [Abstract][Full Text] [Related]
49. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF
J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071
[TBL] [Abstract][Full Text] [Related]
50. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
51. DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction.
Wang J; Zhang J; Lin X; Wang Y; Wu X; Yang F; Gao W; Zhang Y; Sun J; Jiang C; Xu M
J Mol Cell Cardiol; 2021 Feb; 151():3-14. PubMed ID: 33130149
[TBL] [Abstract][Full Text] [Related]
52. Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC.
Chou JC; Lieu FK; Ho DM; Shen HY; Lin PH; Hu S; Wang SW; Lin H; Wang PS
Chemosphere; 2021 Feb; 264(Pt 1):128604. PubMed ID: 33268090
[TBL] [Abstract][Full Text] [Related]
53. STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.
Looyenga BD; Hutchings D; Cherni I; Kingsley C; Weiss GJ; Mackeigan JP
PLoS One; 2012; 7(2):e30820. PubMed ID: 22319590
[TBL] [Abstract][Full Text] [Related]
54. ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.
Zhou H; Cai L; Zhang X; Li A; Miao Y; Li Q; Qiu X; Wang E
Lab Invest; 2018 May; 98(5):670-681. PubMed ID: 29382922
[TBL] [Abstract][Full Text] [Related]
55. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
[TBL] [Abstract][Full Text] [Related]
56. IL-17 promoted metastasis of non-small-cell lung cancer cells.
Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
[TBL] [Abstract][Full Text] [Related]
57. [The expressions of STAT3, WWOX and c-myc in human non small cell lung cancer tissue and correlativity analysis].
Hu FY; Wang LP; Hou LL; Yin G; Wang HC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1203-5, 1209. PubMed ID: 21138684
[TBL] [Abstract][Full Text] [Related]
58. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model.
Yun HM; Park KR; Park MH; Kim DH; Jo MR; Kim JY; Kim EC; Yoon DY; Han SB; Hong JT
Free Radic Biol Med; 2015 Mar; 80():136-44. PubMed ID: 25582888
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
60. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma.
Qiao W; Han Y; Jin W; Tian M; Chen P; Min J; Hu H; Xu B; Zhu W; Xiong L; Lin Q
Tumour Biol; 2016 Feb; 37(2):2575-86. PubMed ID: 26392108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]